NAVAMEDIC (NAVA.OL) Stock Overview
Europe - OSL:NAVA - NO0010205966 - Common Stock
NAVA.OL Key Statistics, Chart & Performance
The current stock price of NAVA.OL is 23.5 NOK. In the past month the price increased by 10.33%. In the past year, price decreased by -6%.
NAVA.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 50.7 | 667.44B | ||
| LLY.DE | ELI LILLY & CO | 50.73 | 667.92B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.87 | 444.61B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 18.29 | 393.86B | ||
| JNJ.DE | JOHNSON & JOHNSON | 18.28 | 393.62B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 14.45 | 248.76B | ||
| 1ROG.MI | ROCHE HOLDING AG-GENUSSCHEIN | 13.92 | 239.54B | ||
| 1NOVN.MI | NOVARTIS AG-REG | 14.74 | 214.88B | ||
| NOT.DE | NOVARTIS AG-REG | 14.96 | 218.05B | ||
| 1SAN.MI | SANOFI | 14.36 | 215.27B | ||
| SNW.DE | SANOFI | 14.45 | 216.58B | ||
| SAN.PA | SANOFI | 14.33 | 214.78B |
Related stock screener links
About NAVA.OL
Company Profile
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 42 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Company Info
NAVAMEDIC
Henrik Ibsens gate 100
Oslo OSLO NO
Employees: 45
Phone: 4767112540
NAVAMEDIC / NAVA.OL FAQ
Can you describe the business of NAVAMEDIC?
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 42 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
What is the current price of NAVA stock?
The current stock price of NAVA.OL is 23.5 NOK. The price increased by 5.86% in the last trading session.
Does NAVA stock pay dividends?
NAVA.OL does not pay a dividend.
How is the ChartMill rating for NAVAMEDIC?
NAVA.OL has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the number of employees for NAVAMEDIC?
NAVAMEDIC (NAVA.OL) currently has 45 employees.
What is NAVAMEDIC worth?
NAVAMEDIC (NAVA.OL) has a market capitalization of 563.53M NOK. This makes NAVA.OL a Small Cap stock.
NAVA.OL Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to NAVA.OL. When comparing the yearly performance of all stocks, NAVA.OL is a bad performer in the overall market: 75.71% of all stocks are doing better.
NAVA.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NAVA.OL. While NAVA.OL seems to be doing ok healthwise, there are quite some concerns on its profitability.
NAVA.OL Financial Highlights
Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of -1.91. The EPS decreased by -236.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.84% | ||
| ROE | -15.33% | ||
| Debt/Equity | 0.33 |
NAVA.OL Forecast & Estimates
7 analysts have analysed NAVA.OL and the average price target is 40.8 NOK. This implies a price increase of 73.62% is expected in the next year compared to the current price of 23.5.
For the next year, analysts expect an EPS growth of -111.04% and a revenue growth 12.65% for NAVA.OL